|
|
||||||||
1 Hypoxia Research Unit, Health and Exercise Sciences Research Laboratory, School of Applied Sciences, University of Glamorgan, South Wales, CF37 1DL; 2 Cellular Nutrition Research Group, University Department of Biochemistry, University of Oxford, Oxford, OX1 3QU; and 3 Gastroenterology Laboratory, Department of Medicine, Royal Postgraduate School, Hammersmith Hospital, London, United Kingdom W12 ONN
| |
ABSTRACT |
|---|
|
|
|---|
The purpose of the present investigation was to determine the independent effects of hypoxia and physical exercise on peripheral cholecystokinin (CCK) metabolism in humans. Thirty-two physically active men were randomly assigned in a double-blind manner to either a normoxic (N; n = 14) or hypoxic (H; n = 18) group. During the acute study, subjects in the H group only participated in two tests, separated by 48 h, which involved a cycling test to exhaustion in normobaric normoxia and normobaric hypoxia (inspired O2 fraction = 0.21 and 0.16, respectively). In the intermittent study, N and H groups cycle-trained for 4 wk at the same relative exercise intensity in both normoxia and hypoxia. Acute normoxic exercise consistently raised plasma CCK during both studies by 290-723%, which correlated with increases in the plasma ratio of free tryptophan to branched chain amino acids (r = 0.58-0.71, P < 0.05). In contrast, acute hypoxic exercise decreased CCK by 7.0 ± 5.5 pmol/l, which correlated with the decrease in arterial oxygen saturation (r = 0.56, P < 0.05). In the intermittent study, plasma CCK response at rest and after normoxic exercise was not altered after physical training, despite a slight decrease in adiposity. We conclude that peripheral CCK metabolism 1) is more sensitive to acute changes than chronic changes in energy expenditure and 2) is potentially associated with acute changes in tissue PO2 and metabolic precursors of cerebral serotoninergic activity.
5-hydroxytryptamine; satiety; caloric intake; adipose tissue; aerobic capacity
| |
INTRODUCTION |
|---|
|
|
|---|
ENVIRONMENTAL HYPOXIA EXERTS potent anorectic effects and thus contributes to the hypophagia and cachexia frequently experienced during prolonged exposure to high altitude (2). Changes in long- and short-term signaling molecules that regulate food intake and energy homeostasis suggest a metabolic basis for these phenomena. Serum leptin has previously been shown to increase at 4,559 m (30), and, in a separate study, our laboratory recently demonstrated a marked increase in the plasma concentration of the satiety neuropeptide cholecystokinin (CCK) at 5,100 m, which was associated with a progressive and selective loss of torso adipose tissue (5). Furthermore, subjects with acute mountain sickness (AMS) presented markedly elevated resting plasma concentration ratios of free tryptophan to branched chain amino acids (BCAA) compared with apparently healthy controls without AMS (4). This may theoretically increase the formation of 5-hydroxytryptamine (5-HT) in the brain (6). The fact that resting plasma CCK was also elevated in these subjects may suggest a possible association between serotoninergic activity and peripheral CCK release.
Isolating the stimuli and potential mechanisms responsible for these metabolic changes has proved elusive because of the logistical limitations imposed by mountaineering expeditions, particularly the lack of normoxically exposed control groups. To our knowledge, the independent effects of acute/chronic changes in energy expenditure and whether peripheral CCK metabolism is altered by more modest reductions in ambient PO2, both important issues, have not been investigated.
Therefore, the present investigation was designed to systematically examine 1) the independent effects of acute, intermittent physical exercise and moderate normobaric hypoxia and 2) the potential association between selected amino acids that are known to influence serotoninergic activity and CCK turnover in a cohort of physically active men.
We hypothesized that, if an association exists between cerebral
serotoninergic activity and the physiological regulation of peripheral
CCK secretion, then the plasma CCK response would be sensitive to
changes in the circulating venous concentration of nonesterified fatty
acids (NEFA), free tryptophan, and BCAA. An increase in NEFA would be
expected, via competitive inhibition, to decrease the proportion of
tryptophan bound to albumin and to thus increase the free concentration
(13). A decrease in the plasma concentration of BCAA due
to an increased oxidation rate would further increase the plasma
concentration ratio of free tryptophan to BCAA. Because BCAA compete
with tryptophan and other aromatic acids for transport across the
blood-brain barrier on the same large neutral amino acid carrier, an
increase in this ratio would favor the entry of free tryptophan into
the brain, in which it is converted to 5-HT (6). We
therefore anticipated a synergistic effect for acute hypoxia and
physical exercise on CCK release due to a more pronounced mobilization
of NEFA from adipose tissue and intramuscular stores, secondary to
increased
1- or
2-adrenoreceptor
activation. Endurance training is associated with an overall reduction
in plasma NEFA (20) and an increase in intramuscular
glycogen. The latter would effectively decrease the required amount of
amino acid oxidation to maintain tricarboxylic acid intermediates, thus
increasing plasma BCAA. In light of these findings, we also predicted a
decrease in the plasma CCK response after intermittent hypoxic
training, subsequent to a decrease in serotoninergic activity.
| |
METHODS |
|---|
|
|
|---|
Subjects
Subjects were excluded from the study if they had any history of digestive system disease, gastrointestinal distress, or evidence of any viral/bacterial infection or were smokers. Other exclusion criteria included prescribed antidepressants or any medication known to affect gastric motility or any other aspect of digestive function. After a detailed medical examination, written, informed consent was obtained from 32 physically active men who were university students [aged 22 ± 3 (SD) yr , body mass index (BMI) = 23.6 ± 1.6 kg/m2, and maximal aerobic capacity (
O2 max) = 50 ± 9 ml · kg
1 · min
1]. Ethical
permission for the study was obtained from the Bro Taff Health Authority.
Experimental Design
Subjects were randomly assigned, in a double-blind manner, to either a normoxic (n = 14) or a hypoxic (n = 18) group that was matched for a variety of physical characteristics (Table 1). An overview of the experimental design is presented in Fig. 1.
|
|
Acute study. The hypoxic group only participated in the acute study, which was designed to investigate the effects of acute normobaric hypoxia on the plasma CCK response at rest and during maximal exercise. Subjects were randomly assigned to perform a normobaric normoxic [inspired O2 fraction (FIO2) = 0.21] and normobaric hypoxic (FIO2 = 0.16) test. Each test involved 30 min of seated rest (passive state) that was preceded by a standardized cycling test to volitional exhaustion (active state). The tests were separated by 48 h to ensure full recovery, as previously established in our laboratory's pilot studies (DM Bailey, unpublished observations). The respective inspirates were regulated by continuously directing medical grade compressed gas mixtures (either 20.9% O2-balanced N2 or 16.0% O2-balanced N2; British Oxygen, Salford, England, UK) into a series of 1,000-liter plastic bags at the prevailing barometric pressure, which was determined using a mercury Fortin barometer (Cranleigh, Salford, UK). The bag system was connected to a four-way valve and a 2-m length of Falconia tubing (3.18 cm ID) attached to the inspiratory port of a two-way, non-rebreathing valve (2400 series, Hans Rudolph).
Intermittent study. The intermittent study was designed to investigate the effects of 4 wk of intermittent hypoxic training on resting and exercise plasma CCK responses. Normoxic and hypoxic groups performed an exercise test in normobaric normoxia before (Pre) and after (Post) a supervised physical training program. Pre testing for the hypoxic group was established during the acute study, as previously described. Both groups exercised for the same duration, at the same relative exercise intensity, in either normoxia or hypoxia. The inspired partial pressure of oxygen (PIO2) in hypoxia ranged between 111 and 118 Torr and between 147 and 152 Torr in normoxia. The hypoxic stimulus applied in the present study was substantially higher than that encountered in our laboratory's previous study (5), which was conducted at 5,100 m (PIO2 ~76 Torr).
Physical training program. A detailed description of the physical training program was previously published (3). Briefly, all subjects performed cycling exercise at precisely the same time of day every Monday, Wednesday, and Friday for a 4-wk training period. Each session was supervised by a physiologist, had a 20-min duration for weeks 1-2, and was increased to 30 min for weeks 3-4 at 70, 75, 80, and 85% of the maximal heart rate (HRmax), which was determined during either the normoxic or hypoxic Pre test (see Fig. 1). Pedalling frequency was maintained at 70 rpm, and the work load was adjusted continuously to achieve the desired HR. Desired HR was determined via an electrocardiographically calibrated, short-range telemetry system (Polar Vantage NV). Normoxic and hypoxic gas mixtures were presented double-blind to subjects in the normoxic and hypoxic groups, respectively.
Dietary analysis and control. A self-reporting dietary analysis (NutriCheck, Health Options) was completed 7 days before the start and end of the study. Analysis of caloric intake and composition revealed no between-group differences, and thus subjects were subsequently advised to maintain their normal dietary habits for the duration of the experimental period. Behavioral compliance was established by conducting daily interviews with each subject, a physiologist, and a qualified nutritionist.
Resting Measurements
Anthropometry. After a 12-h overnight fast and after voiding and defecation, nude body mass and stature were determined using a balanced weighing scales and stadiometer (Seca, Cardiokinetics). Body fat percentage was calculated using the Durnin and Womersley equation (17) and the measurement of the sum of four skinfolds taken from the medial aspect of the biceps, triceps, subscapular, and suprailliac sites using a calibrated Harpenden skinfold caliper (British Indicators). A flexible metallic tape measure (Holtain, Crymych, UK) was used to assess waist (taken at the mid-umbilicus) and hip circumference (widest point).
Hematology. Subjects were instructed to refrain from physical exercise and alcohol consumption 48 h before arrival at the laboratory after a 12-h overnight fast. A venous sample was obtained at the same time of day for each subject after 30 min of supine rest to control for plasma volume shifts. An exercise venous sample was obtained immediately after a cycling test to volitional exhaustion and was subsequently corrected for plasma volume shifts (16).
NEFA and glycerol. Enzymatic assays were used to analyze plasma concentrations of NEFA (Behring Diagnostics, La Jolla, CA) and glycerol (Wako Chemicals, Neuss, Germany). The intra- and interassay coefficients of variation (CV) were (respectively) 1.6 and 5% for NEFA and 2 and 5% for glycerol.
Whole blood lactate.
An arterialized capillary blood sample was obtained from a hyperaemic
earlobe and analyzed for whole blood lactate concentration ([La
]B) using an automated analyzer
(Champion PLM-5, Analox). The intra- and interassay CVs were 1% and
<5%, respectively.
Glucose. Plasma glucose was analyzed via the glucose/HK method (Boehringer Manheim). The intra- and interassay CVs were 2 and 5%, respectively.
Free tryptophan. Plasma free tryptophan was separated from albumin-bound tryptophan by using the ultrafiltration method according to Bloxam et al. (8). The plasma concentration of tryptophan in the ultrafiltrate (free tryptophan) was subsequently measured by the fluorimetric method of Denckla and Dewey (15), as modified by Bloxam and Warren (9). The intra- and interassay CVs were <5%.
BCAA. The plasma concentration of BCAA was measured by using the enzymatic method described by Livesey and Lund (23) with modifications. The intra- and interassay CVs were <5%.
CCK radioimmunoassay. CCK was measured by a specific radioimmunoassay, as previously described (5). The intra- and interassay CVs were 6.2 and 12.1%, respectively.
Physical Exercise Test
After a 2-wk habituation period, each subject performed a continuous incremental cycling test (Monark 824E Ergomedic) to volitional exhaustion, as previously described (3). Each subject started unloaded cycling exercise at 70 rpm for the first 4 min and power output was increased by 50 W every 4 min for the first 5 stages and thereafter by 25 W every minute until volitional exhaustion. Each subject was instructed to signal clearly to the investigators when they considered they could continue at the specified power output for no longer than 60 s. Pilot study data prove this is an accurate method for the determination of
O2 max
using established physiological criteria. Rating of perceived exertion (RPE), arterial hemoglobin oxygen saturation (SaO2),
and HR were measured continuously. SaO2 was determined
by using an earlobe pulse oxymeter (model 8800, Nonin) and validated in
hypoxia, with a reported accuracy of ±1%.
[La
]B was assayed from arterialized
capillary blood that was taken from a hyperemic earlobe during the last
30 s of each 4-min stage and 10 s before completion of the
test. Expiratory gases were collected during the last 60 s of the
4-min stages and during the last 60 s of the test and were
analyzed using a semi-automated Douglas Bag system. Gas fractions were
measured using paramagnetic O2 and infrared CO2
analyzers (1400 series Analyzer, Servomex, Crowborough, UK), which were
calibrated with precision-analyzed quality gas mixtures containing pure
nitrogen and 17% O2-5% CO2. The volume of
expired gas was measured using a dry gas meter (Harvard, Crowborough,
UK), which was calibrated with a 600-liter Tissot spirometer (Collins).
Statistics
Repeated Kolmogorov-Smirnov and Shapiro-Wilk W tests confirmed that all dependent variables were normally distributed. Between-group comparisons of baseline physical characteristics (Table 1) were compared using an independent samples t-test. Physiological responses to acute normobaric hypoxia (Table 2) were assessed using a paired samples t-test. Anthropometric and dietary data (Table 3) were analyzed using a two-way split plot [A × (B)] mixed ANOVA that incorporated one between-subjects (group: normoxic vs. hypoxic) and one within-subjects (time: Pre vs. Post) factor. Acute responses (Fig. 2.) were analyzed using a two-factor repeated measures ANOVA(state: rest vs. exercise × condition: normoxic vs. hypoxic ). With the exception of the plasma ratio of free tryptophan to BCAA, intermittent training responses (Table 4, Fig. 3) were analyzed using a three-way [A × (B × C)] mixed ANOVA with one between-subjects factor (group) and two within-subjects factors (state and time). After simple main effects and interaction effects, Bonferroni-corrected, paired-sample t-tests were applied to make a posteriori comparisons at each level of the between-subjects factor. Between-subjects differences were analyzed using a one-way ANOVA with an a posteriori Tukey honestly significant difference test at selected levels of the within-subjects factors. Comparisons of the plasma concentration ratios of free tryptophan to BCAA were assessed using nonparametric statistics. Within-subjects effects were analyzed using a Friedman test and Bonferonni-corrected Wilcoxon matched pairs signed-rank tests. Between-subjects effects were analyzed using a Kruskal-Wallis test and Bonferonni-corrected Mann-Whitney U tests. We used a Pearson product moment correlation to analyze the relationship between selected dependent variables (Fig. 4). Significance for all two-tailed tests was established at an alpha level of P
0.05, and data are expressed as means ± SD.
|
|
|
|
|
|
| |
RESULTS |
|---|
|
|
|---|
Acute Responses
Arterial desaturation was more marked during maximal exercise in normobaric hypoxia, resulting in a 10 ± 4% decrease in absolute
O2 (Table 2). Figure 2 illustrates the
marked increase in plasma CCK relative to the resting value after
normoxic exercise (from 10.7 ± 4.5 to 50.6 ± 34.7 pmol/l,
P < 0.05), whereas a decrease was observed after
hypoxic exercise (from 9.9 ± 4.8 to 3.7 ± 2.5 pmol/l,
P < 0.05). The suppressive effects of hypoxia were
clearly not evident during passive exposure. The decrease in CCK during hypoxic exercise (exercise minus rest value) was correlated with the
decrease in SaO2 (r = 0.56, P < 0.05). The increase in CCK during the normoxic
test was related to absolute
O2 max (r = 0.56, P < 0.05).
Intermittent Training Responses
Physical training.
All subjects successfully completed the training program, and only 5 out of 384 individual sessions were missed due to injury. There were no
between-group differences for weeks 1-4 for power output, rate pressure product, or RPE, whereas SaO2
was lower and [La
]B response was higher
during hypoxic training. Thus both relative and absolute training
intensities were comparable between groups.
Plasma CCK response. Four weeks of intermittent normoxic or hypoxic training did not affect the resting or exercise plasma CCK response in normoxia (Fig. 3).
Caloric intake, dietary composition, and anthropometric characteristics. Total caloric intake and dietary composition did not change during the experimental period and was not different between groups (Table 3). Physical training decreased the sum of skinfolds, fat mass, and waist-to-hip ratio, but no changes were observed for body mass and fat-free mass. However, these variables did not differ between groups either before or after training.
O2 max.
Intermittent hypoxic training increased
O2 max from 3.49 ± 0.47 to
3.96 ± 0.60 l/min (P < 0.05 vs. Pre), whereas no
changes were observed after a comparable program of normoxic exercise.
Changes in
O2 max (Post
Pre)
were not related to changes in resting or exercise CCK in either group.
Metabolic Responses
NEFA. Acute exercise increased the plasma concentration of NEFA during both Pre and Post tests (Table 4). Physical training had no effect on either the resting or exercise NEFA response.
Glycerol. Acute exercise increased the plasma concentration of glycerol during both Pre and Post tests (Table 4). Physical training resulted in a greater increase in glycerol during acute exercise (pooled normoxic + hypoxic group values, P < 0.05 vs. Pre), but no effects were observed at rest. Maximal exercise resulted in a greater increase in glycerol after hypoxic training.
[La
]B and glucose.
The increase in exercise [La
]B was more
marked in the normoxic group during the Pre test (Table 4). Both
normoxic and hypoxic training decreased resting
[La
]B; however, no effects were observed
for maximal exercise. Plasma glucose decreased after training and was
greater in the normoxic group throughout the study (Table 4). However,
there were no between-group differences as a function of either time or state.
Free tryptophan and BCAA.
Maximal exercise increased the plasma concentration ratio of free
tryptophan to BCAA due to an increase in plasma free tryptophan and a
decrease in BCAA (Table 4). The increase in free tryptophan (pooled
maximal exercise
rest values) correlated with the increase in
NEFA (r = 0.61, P < 0.05). Pooled
values for free tryptophan and plasma concentration ratio of free
tryptophan to BCAA (rest + maximal exercise) increased in the
hypoxic group only during the Post test (P < 0.05 vs.
Pre). Physical training had no effect on the plasma BCAA. The increase
in the plasma concentration ratio of free tryptophan to BCAA correlated
with the increase in CCK (r = 0.58-0.71,
P < 0.05) during all acute normoxic exercise tests (Fig. 4).
| |
DISCUSSION |
|---|
|
|
|---|
The present study was undertaken to examine the independent effects of physical exercise and moderate normobaric hypoxia on peripheral CCK metabolism in humans. The potential relationship between plasma CCK and changes in selected amino acids that could potentially affect cerebral serotoninergic activity was also investigated.
Our results highlight three important findings. First, relative to resting conditions, plasma CCK increased markedly after acute normoxic exercise, whereas a decrease was observed during acute hypoxic exercise. Second, the plasma CCK response appeared to be more sensitive to acute, rather than chronic, changes in energy expenditure; 4 wk of intermittent normoxic/hypoxic training did not alter the CCK response at rest or immediately after normoxic exercise. Third, we have described potential relationships between peripheral CCK secretion and acute changes in tissue PO2 and metabolic precursors of cerebral serotoninergic activity.
Physical Exercise and Hypoxia
Acute exercise and hypoxia.
In support of our previous observations (5), acute
normoxic exercise was a potent CCK releaser, a response that was
independent of either local or systemic changes in adiposity and was
therefore related to changes in the metabolic milieu invoked by
physical exercise per se. In marked contrast to our original
hypothesis, acute hypoxic exercise resulted in a decrease in plasma
CCK. Assuming that the physical exercise component of the acute hypoxic
test induced an increase in CCK similar to that observed in normoxia (+473% relative to resting control), the inhibitory effect of hypoxia
on CCK release (
536%) appeared more marked. Although it is possible
that differences in the exercise load between tests could have
accounted for the differential effects on CCK metabolism, the lack
of correlation between absolute CCK values and exercise duration or
maximal power output tends to challenge this contention.
Intermittent exercise and hypoxia. A previous study demonstrated that the resting serum concentration of CCK was not different between long-distance women runners and age-weight matched sedentary controls (19), suggesting that baseline CCK is relatively resistant to chronic changes in energy expenditure. Our data tend to support these findings, as 4 wk of physical training did not effect the plasma CCK response either at rest or during maximal exercise, which may have implications for individuals attempting to lose body mass. However, the earlier study identified an attenuation of the CCK and insulin response to a standardized meal, and subjective ratings of hunger were elevated in the athletes (19), which may reflect an adaptation to physical training.
A selective increase in absolute
O2 max
was observed after intermittent hypoxic training only, which was the
subject of a recent study (3). This increase was
independent of changes in resting hemoglobin concentration and was
possibly associated with other unquantified central and/or peripheral
adaptations in the ultrastructural and biochemical properties of
skeletal muscle.
Caloric intake did not change, despite a moderate reduction in
adiposity, which, according to the most recent theory of energy homeostasis (26), would be expected to activate the
neuronal activity of anabolic effector pathways that initiate metabolic responses to increase caloric intake. Assuming that an energy expenditure of 14.6 MJ is required to metabolize 0.45 kg of adipose tissue (1), the generalized decrease in fat mass after
training (
1.3 ± 1.0 kg) would equate to a cumulative energy
deficit of ~42 MJ. Whether perturbations in peripheral CCK metabolism
contributed to this relative hypophagia remains to be established, and
future studies need to more directly examine changes in CCK dynamics and acute satiety/hunger ratings in response to a test meal. It is also
important to emphasize that changes in long-term adiposity signals such
as leptin and/or insulin can effectively modulate the satiogenic
sensitivity of CCK; satiety induced by intraperitoneal CCK
administration has been shown to increase with
intracerebroventricular infusion of insulin (18) or a
systemic injection of leptin (24). Therefore, the clinical
implications of changes in absolute concentrations of plasma CCK need
to be considered with tentative caution in the absence of other
long-term signaling molecules.
Cerebral Serotoninergic Activity
Our findings demonstrate a potential association between peripheral CCK and 5-HT during acute normoxic exercise in humans. Recent neuropharmacological studies have also demonstrated an intimate relationship between 5-HT, CCK, and nutritional intake. In one study, the inhibitory effect of CCK on food intake was antagonized by 5-HT blockers (28), most likely mediated by 5-HT2C receptor inactivation (25). In a separate study, the effect of an antiobesity serotoninergic agonist (dex-fenfluramine) was blocked by the CCK-A receptor antagonist devazepide (12).Acute normoxic exercise altered the venous concentration of key amino acids previously shown to alter 5-HT synthesis in the animal brain (7). A slight decrease in the plasma concentration of BCAA was observed and was presumably due to an increase in the rate of oxidation by skeletal muscle. The increase in free tryptophan was associated with an increase in NEFA, which, via competitive inhibition, decreases the binding affinity of tryptophan to albumin, thus increasing the free (i.e., non-albumin-bound) concentration (12). Animal studies have demonstrated that an exercise-induced increase in the plasma ratio of free tryptophan to BCAA (+36 vs. +40% in the present study) accelerates tryptophan flux across the blood-brain barrier, thus increasing the synthesis of 5-HT (+28%) in the hypothalamus (7). This is an area of the brain in which changes in CCK have also been observed during stress procedures (27). The circulating plasma concentrations of NEFA, free tryptophan, and BCAA may therefore serve as putative metabolic signals associated with the peripheral release of satiety neuropeptides.
We can only speculate as to whether the changes in the plasma amino
acid ratio were sufficient to alter cerebral 5-HT, clarification of
which, in the human, represents a formidable analytical challenge. However, metabolic control logic would suggest that any increase in
this plasma ratio would theoretically increase cerebral 5-HT synthesis,
as none of the metabolic reactions in the brain approaches saturation
with pathway substrate. Systemic 5-HT synthesis has been shown, in
previous studies, to increase by ~50% during 60 min of hypoxic
exercise at FIO2
0.14 (29). However, we elected not to perform this measurement
because of the analytical deficiencies of this assay. The plasma
concentration of 5-HT depends on the number of damaged platelets in the
circulation, which, to our knowledge, cannot be accurately quantified
(D. Perrett, personal communication).
Acute hypoxia was previously shown to decrease the synthesis of 5-HT in the whole brain of rats (14), and a decrease in the venous concentration of prolactin, an indirect neuroendocrine marker of serotoninergic activity, was also demonstrated in humans acutely exposed to an FIO2 of 0.145 (10). These observations may lend further support to the proposed mechanism and provide a possible explanation for the acute hypoxic depression of plasma CCK seen in the present study. However, it was unfortunate that we did not establish whether hypoxic exercise decreased NEFA mobilization and the subsequent plasma amino acid ratio to further consolidate our original hypothesis. Alternatively, intravenous infusion of sulfated CCK octapeptide (CCK-8) was shown to increase the secretion rates of prolactin, cortisol, and growth hormone in humans (11), which also suggests a potential regulatory role of hypothalamic CCK per se in the activity of the hypothalamo-hypophyseal-adrenal axis.
The plasma ratio of free tryptophan to BCAA and CCK appeared to be more sensitive to acute compared with chronic changes in energy expenditure. The plasma ratio increased after intermittent hypoxic training only (pooled rest + exercise values), whereas a time × group interaction effect was not observed for plasma CCK. This apparent disassociation between the plasma ratio and CCK may be explained by changes in the sensitivity of brain serotoninergic function. A 16-wk endurance training program was shown to downregulate serotoninergic activity by ~30% in response to a selective 5-HT agonist (21).
In conclusion, the present findings demonstrated a consistent increase in plasma CCK after acute normoxic exercise, whereas a decrease was observed after acute, normobaric hypoxic exercise. The suppressive effects of acute hypoxia were only apparent during active as opposed to passive exposure and may be associated with changes in tissue PO2. In contrast, 4 wk of intermittent training had no effect on either the resting or exercise CCK response, despite a slight decrease in adiposity. The present findings also suggest a possible association between peripheral CCK secretion and metabolic precursors of serotoninergic activity, including NEFA, free tryptophan, and BCAA. Imaging studies combined with pharmacological intervention incorporating 5-HT receptor agonists/antagonists would establish whether a cause-and-effect relationship exists between cerebral serotoninergic activity and peripheral CCK secretion in humans.
| |
ACKNOWLEDGEMENTS |
|---|
We remember the late Simon Humphrey and the late Dr. Gail Butterfield, who remain constant sources of inspiration. We also extend our thanks to the undergraduate students of the University of Glamorgan that volunteered for the study; to the doctoral students who assisted in data collection, particularly M. Richards; to N. Hiscock, J. McGuire, S. Lucas, and M. Jordinson for kind efforts with the analysis of blood samples; and to Professor K. Frayn for informative discussions.
| |
FOOTNOTES |
|---|
This research was supported by the British Oxygen Company.
Address for reprint requests and other correspondence: D. M. Bailey, Hypoxia Research Unit, Health and Exercise Sciences Research Lab., School of Applied Sciences, Univ. of Glamorgan, South Wales, UK CF37 1DL (E-mail: dbailey1{at}glam.ac.uk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 11 April 2000; accepted in final form 27 July 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
American College of Sports Medicine.
Guidelines for Exercise Testing and Prescription (4th ed). Philadelphia, PA: Lea and Febiger, 1991.
2.
Bailey, DM.
Acute mountain sickness: the "poison of the pass."
Br. J Sports Med
33:
376,
1999[Web of Science][Medline].
3.
Bailey, DM,
Davies B,
and
Baker J.
Training in hypoxia: modulation of metabolic and cardiovascular risk factors in men.
Med Sci Sports Exerc
32:
1058-1066,
2000[Web of Science][Medline].
4.
Bailey, DM,
Davies B,
Milledge JS,
Castell LM,
Newsholme EA,
Richards M,
Jordinson M,
and
Calam J.
A metabolic role for elevated plasma cholecystokinin in the anorexia and weight loss of acute mountain sickness in man? (Abstract).
J Physiol (Lond)
525P:
C33,
2000.
5.
Bailey, DM,
Davies B,
Milledge JS,
Richards M,
Williams SRP,
Jordinson M,
and
Calam J.
Elevated plasma cholecystokinin at high altitude: metabolic implications for the anorexia of acute mountain sickness?
J High Alt Med Biol
1:
1-8,
2000.
6.
Blomstrand, E,
Celsing F,
and
Newsholme EA.
Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue.
Acta Physiol Scand
133:
115-121,
1988[Web of Science][Medline].
7.
Blomstrand, E,
Perrett D,
Parry-Billings M,
and
Newsholme EA.
Effect of sustained exercise on plasma amino acid concentrations and on 5-hydroxytryptamine metabolism in six different brain regions in the rat.
Acta Physiol Scand
136:
473-481,
1989[Web of Science][Medline].
8.
Bloxam, DL,
Hutson PH,
and
Curzon G.
A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma.
Anal Biochem
83:
130-142,
1977[Web of Science][Medline].
9.
Bloxam, DI,
and
Warren WH.
Error in the determination of tryptophan by the method of Denckla and Dewey. A revised procedure.
Anal Biochem
60:
621-625,
1974[Web of Science][Medline].
10.
Bouissou, P,
Brisson GR,
Péronnet F,
Hélie R,
and
Ledoux M.
Inhibition of exercise-induced blood prolactin response by acute hypoxia.
Can J Sport Sci
12:
49-50,
1987[Web of Science][Medline].
11.
Calogero, AE,
Nicolosi AM,
Moncada ML,
Coniglione F,
Vicari E,
Polosa P,
and
D'Agata R.
Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans.
Neuroendocrinology
58:
71-76,
1993[Web of Science][Medline].
12.
Cooper, SJ,
Dourish CT,
and
Barber DJ.
Reversal of the anorectic effect of (+) fenfluramine in the rat by the selective cholecystokinin antagonist MK-329.
Br J Pharmacol
99:
65-70,
1990[Web of Science][Medline].
13.
Curzon, G,
Friedel J,
and
Knott PJ.
The effect of fatty acids on the binding of tryptophan to plasma protein.
Nature
242:
198-200,
1973[Medline].
14.
Davis, JN,
Carlson A,
MacMillan V,
and
Siesjö BK.
Brain tryptophan hydroxylation: dependence on arterial oxygen tension.
Science
182:
72-74,
1973
15.
Denckla, WD,
and
Dewey HK.
The determination of tryptophan in plasma, liver, and urine.
J Lab Clin Med
69:
160-169,
1967[Web of Science][Medline].
16.
Dill, DB,
and
Costill DL.
Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
J Appl Physiol
37:
247-248,
1974
17.
Durnin, JW,
and
Womersley J.
Body fat assessed from total body density and its estimation from skinfold thickness measurements on 481 men and women aged from 16 to 72 years.
Br J Nutr
323:
77-97,
1974.
18.
Figlewicz, DP,
Stein LJ,
West D,
Porte D, Jr,
and
Woods SC.
Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons.
Am J Physiol Regulatory Integrative Comp Physiol
250:
R856-R860,
1986
19.
Hirschberg, AL,
Lindholm C,
Carlström K,
and
Schoultz BV.
Reduced serum cholecystokinin response to food intake in female athletes.
Metabolism
43:
217-222,
1994[Web of Science][Medline].
20.
Hurley, BF,
Nemeth PM,
Martin WH, III,
Hagberg JM,
Dalsky GP,
and
Holloszy JO.
Muscle triglyceride utilization during exercise: effect of training.
J Appl Physiol
60:
562-567,
1986
21.
Jakeman, PM.
Amino acid metabolism, branched-chain amino acid feeding and brain monoamine function.
Proc Nutr Soc
57:
35-41,
1998[Web of Science][Medline].
22.
Lieverse, RJ,
Jansen JB,
Masclee AA,
and
Lamers CB.
Satiety effects of a physiological dose of cholecystokinin in humans.
Gut
36:
176-179,
1995
23.
Livesey, G,
and
Lund P.
Enzymatic determination of branched-chain amino acids and 2-oxoacids in rat tissues.
Biochem J
188:
705-713,
1980[Web of Science][Medline].
24.
Matson, CA,
Wiater M,
Kuiper JL,
and
Weigle DS.
Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake.
Peptides
18:
1275-1278,
1997[Web of Science][Medline].
25.
Poeschia, B,
Gibbs J,
Simansky KJ,
Greenberg D,
and
Smith GP.
Cholecystokinin-induced satiety depends on activation of 5-HT1C receptors.
Am J Physiol Regulatory Integrative Comp Physiol
264:
R62-R64,
1993
26.
Schwartz, MW,
Baskin DG,
Kaiyala KJ,
and
Woods SC.
Model for the regulation of energy balance and adiposity by the central nervous system.
Am J Clin Nutr
69:
584-596,
1999
27.
Siegel, RA,
Düker EM,
Pahnke U,
and
Wuttke W.
Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus.
Neuroendocrinology
46:
75-81,
1988.
28.
Stallone, D,
Nicolaidis S,
and
Gibbs J.
Cholecystokinin-induced anorexia depends on serotoninergic function.
Am J Physiol Regulatory Integrative Comp Physiol
256:
R1138-R1141,
1989
29.
Struder, HK,
Hollmann W,
Donike M,
Platen P,
and
Weber K.
Effect of O2 availability on neuroendocrine variables at rest and during exercise: O2 breathing increases plasma prolactin.
Eur J Appl Physiol
74:
443-449,
1996.
30.
Tschöp, M,
Strasburger CJ,
Hartmann G,
Biollaz J,
and
Bärtsch P.
Raised leptin concentrations at high altitude associated with loss of appetite.
Lancet
352:
1119-1120,
1998.
This article has been cited by other articles:
![]() |
C. Martins, L. M Morgan, S. R Bloom, and M D. Robertson Effects of exercise on gut peptides, energy intake and appetite J. Endocrinol., May 1, 2007; 193(2): 251 - 258. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |